Danaher Corporation
DHR
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterizatioā¦ read more
Healthcare
Diagnostics & Research
47 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$200.06
Price-0.24%
-$0.47
1Y
Price
Market Cap
$140.639b
Large
Price/Earnings 3y Avg5y Avg
25.1x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+29.4%
EBITDA Margin+13.9%
Net Profit Margin+20.2%
Free Cash Flow Margin+29.4%
EBITDA Margin+13.9%
Net Profit Margin+20.2%
Free Cash Flow MarginRevenue
$25.107b
+2.2%
1y CAGR+1.7%
3y CAGR-1.3%
5y CAGREarnings
$4.004b
+10.8%
1y CAGR-4.9%
3y CAGR-12.1%
5y CAGREPS
$5.63
+11.7%
1y CAGR-3.4%
3y CAGR-11.0%
5y CAGRBook Value
$52.592b
$92.367b
Assets$39.786b
Liabilities$26.558b
DebtDebt to Assets
28.7%
3.7x
Debt to EBITDAFree Cash Flow
$5.466b
+3.9%
1y CAGR-1.7%
3y CAGR-6.7%
5y CAGRNo items found.
Press Releases
Statements and updates from the company